|
|
||||||||
Ann Thorac Surg 2001;72:1849-1854
© 2001 The Society of Thoracic Surgeons
a Division of Cardiac Surgery, The Johns Hopkins Medical Institutions and Kennedy-Krieger Research Institute, Baltimore, Maryland, USA
b Division of Cardiovascular Medicine, The Johns Hopkins Medical Institutions and Kennedy-Krieger Research Institute, Baltimore, Maryland, USA
c Division of Neurology, The Johns Hopkins Medical Institutions and Kennedy-Krieger Research Institute, Baltimore, Maryland, USA
d Division of Neuropathology, The Johns Hopkins Medical Institutions, and Kennedy-Krieger Research Institute, Baltimore, Maryland, USA
* Address reprint requests to Dr Baumgartner, Division of Cardiac Surgery, The Johns Hopkins Hospital, Blalock 618, 600 North Wolfe Street, Baltimore, MD 21287, USA
e-mail: wbaumgar{at}csurg.jhmi.jhu.edu
Presented at the Thirty-seventh Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 2931, 2001.
Background. Ischemic preconditioning is an endogenous mechanism whereby brief periods of ischemia render neurons resistant to subsequent lethal insults. This protection appears to alter cellular apoptosis and can be induced by potassium channel openers acting on the inner membrane of the mitochondria (mitoKATP). To test the hypothesis that pharmacologic preconditioning could provide neuroprotection, the mitoKATP opener diazoxide was used in a canine model of brain injury induced by hypothermic circulatory arrest (HCA).
Methods. Seventeen dogs were placed on cardiopulmonary bypass (CPB) and cooled to 18°C. After 2 hours of HCA, animals were rewarmed and weaned from CPB. Six dogs received intravenous diazoxide (2.5 mg/kg bolus 15 minutes prior to CPB, then 0.5 mg/min until circulatory arrest, then restarted for the first hour of rewarming). Six animals received vehicle only. Five received diazoxide and the mitoKATP blocker 5-hydroxydecanoate (5-HD). Using a modified Pittsburgh Canine Neurological Scoring System (0 = normal, 500 = brain death), animals were evaluated every 24 hours for 3 days. The brains were removed and histologic sections of four regions characteristically injured in this model were scored (0 = no injury, 4 = infarction) by a neuropathologist in a blinded fashion.
Results. Clinical scoring showed marked improvement in the diazoxide group at 48 hours (101 ± 10.5 vs 165 ± 14.8, p < 0.01) and 72 hours (54 ± 9.3 vs 137 ± 12.1, p < 0.01). This neuroprotection was attenuated when 5-HD was concomitantly administered. Three of four brain regions typically injured in this model (cortex, hippocampus, and entorhinal cortex) had significant neuron preservation in the diazoxide group. Likewise, combined region scores were significantly improved in the treatment group (1.18 ± 0.2 vs 2.46 ± 0.2, p < 0.01).
Conclusions. Pretreatment with diazoxide resulted in significant improvement in both clinical neurologic scores and histopathology in our model of HCA. This suggests that pharmacologic preconditioning with the mitoKATP channel opener diazoxide may offer effective neuroprotection during HCA.
This article has been cited by other articles:
![]() |
E. S. Weiss, K. K.W. Wang, J. G. Allen, M. E. Blue, L. U. Nwakanma, M. C. Liu, M. S. Lange, J. Berrong, M. A. Wilson, V. L. Gott, et al. Alpha II-spectrin breakdown products serve as novel markers of brain injury severity in a canine model of hypothermic circulatory arrest. Ann. Thorac. Surg., August 1, 2009; 88(2): 543 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Niagara, H. Kh. Haider, S. Jiang, and M. Ashraf Pharmacologically Preconditioned Skeletal Myoblasts Are Resistant to Oxidative Stress and Promote Angiomyogenesis via Release of Paracrine Factors in the Infarcted Heart Circ. Res., March 2, 2007; 100(4): 545 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Williams, C. J. Barreiro, L. U. Nwakanma, M. S. Lange, L. E. Kratz, M. E. Blue, J. Berrong, N. D. Patel, V. L. Gott, J. C. Troncoso, et al. Valproic Acid Prevents Brain Injury in a Canine Model of Hypothermic Circulatory Arrest: A Promising New Approach to Neuroprotection During Cardiac Surgery Ann. Thorac. Surg., June 1, 2006; 81(6): 2235 - 2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Barreiro, J. A. Williams, T. P. Fitton, M. S. Lange, M. E. Blue, L. Kratz, P. B. Barker, M. Degaonkar, V. L. Gott, J. C. Troncoso, et al. Noninvasive Assessment of Brain Injury in a Canine Model of Hypothermic Circulatory Arrest Using Magnetic Resonance Spectroscopy. Ann. Thorac. Surg., May 1, 2006; 81(5): 1593 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Amir, C. Ramamoorthy, R. K. Riemer, V. M. Reddy, and F. L. Hanley Neonatal Brain Protection and Deep Hypothermic Circulatory Arrest: Pathophysiology of Ischemic Neuronal Injury and Protective Strategies Ann. Thorac. Surg., November 1, 2005; 80(5): 1955 - 1964. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Baumgartner Neuroprotection in Cardiac Surgery Ann. Thorac. Surg., June 1, 2005; 79(6): S2254 - S2256. [Full Text] [PDF] |
||||
![]() |
S. Love Establishing preconditions for Balo's concentric sclerosis Brain, May 1, 2005; 128(5): 960 - 962. [Full Text] [PDF] |
||||
![]() |
F. Er, G. Michels, N. Gassanov, F. Rivero, and U. C. Hoppe Testosterone Induces Cytoprotection by Activating ATP-Sensitive K+ Channels in the Cardiac Mitochondrial Inner Membrane Circulation, November 9, 2004; 110(19): 3100 - 3107. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Yeh, Y.-C. Wang, Y.-C. Wu, Y.-M. Lin, and P. J. Lin Ischemic preconditioning or heat shock pretreatment ameliorates neuronal apoptosis following hypothermic circulatory arrest J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 203 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Teshima, M. Akao, R. A. Li, T. H. Chong, W. A. Baumgartner, M. V. Johnston, and E. Marban Mitochondrial ATP-Sensitive Potassium Channel Activation Protects Cerebellar Granule Neurons From Apoptosis Induced by Oxidative Stress Stroke, July 1, 2003; 34(7): 1796 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Munoz, M. Nakazaki, J. C. Goodman, R. Barrios, C. G. Onetti, J. Bryan, and L. Aguilar-Bryan Ischemic Preconditioning in the Hippocampus of a Knockout Mouse Lacking SUR1-Based KATP Channels Stroke, January 1, 2003; 34(1): 164 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xu, Y. Liu, S. Wang, T. McDonald, J. E. Van Eyk, A. Sidor, and B. O'Rourke Cytoprotective Role of Ca2+- Activated K+ Channels in the Cardiac Inner Mitochondrial Membrane Science, November 1, 2002; 298(5595): 1029 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Caparrelli, S. M. Cattaneo II, B. T. Bethea, J. G. Shake, C. Eberhart, M. E. Blue, E. Marban, M. V. Johnston, W. A. Baumgartner, and V. L. Gott Pharmacological preconditioning ameliorates neurological injury in a model of spinal cord ischemia Ann. Thorac. Surg., September 1, 2002; 74(3): 838 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lang-Lazdunski, C. Heurteaux, and M. Lazdunski Diazoxide for cerebral protection during deep hypothermic circulatory arrest: is it really safe? Ann. Thorac. Surg., August 1, 2002; 74(2): 632 - 632. [Full Text] [PDF] |
||||
![]() |
B. F. Buxton Invited commentary Ann. Thorac. Surg., April 1, 2002; 73(4): 1259 - 1260. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |